How could we solve the diagnostic dilemma of doxorubicin toxicity in high-risk patients?
Davutoglu
Vedat
V
Soydinc
Serdar
S
Akdemir
Ilyas
I
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects* / Q000494:pharmacology; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000009:adverse effects* / Q000494:pharmacology; D006331:Heart Diseases / Q000139:chemically induced* / Q000208:ethnology / Q000517:prevention & control; D006801:Humans; D018570:Risk Assessment; D012307:Risk Factors
D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin